Public disclosures

Hochman David P

Company insiders · See Remarks · Director · Orchestra BioMed Holdings, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-09.Following & alerts
Reported transaction lines
1
Buy lines
1
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Hochman David P

See Remarks · Director · Orchestra BioMed Holdings, Inc.

OBIO

Orchestra BioMed Holdings, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Indirect ownership · By the DPH 2008 Trust · Reported balance after transaction: 437916 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. · Chief Executive Officer and Chairperson

2026-11-092026-11-09

≈ $25,000.00

5,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement